🎉 M&A multiples are live!
Check it out!

Imricor Medical Systems Valuation Multiples

Discover revenue and EBITDA valuation multiples for Imricor Medical Systems and similar public comparables like Myomo, InfuSystem, and SmartVest.

Imricor Medical Systems Overview

About Imricor Medical Systems

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.


Founded

2006

HQ

Australia
Employees

n/a

Website

imricor.com

Financials

LTM Revenue $3.0M

LTM EBITDA -$24.2M

EV

$289M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Imricor Medical Systems Financials

Imricor Medical Systems has a last 12-month revenue of $3.0M and a last 12-month EBITDA of -$24.2M.

In the most recent fiscal year, Imricor Medical Systems achieved revenue of $0.6M and an EBITDA of -$18.2M.

Imricor Medical Systems expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Imricor Medical Systems valuation multiples based on analyst estimates

Imricor Medical Systems P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.4M $0.6M XXX XXX XXX
Gross Profit -$1.0M -$0.7M XXX XXX XXX
Gross Margin -248% -116% XXX XXX XXX
EBITDA -$13.7M -$18.2M XXX XXX XXX
EBITDA Margin -3553% -3015% XXX XXX XXX
Net Profit -$10.9M -$14.2M XXX XXX XXX
Net Margin -2820% -2358% XXX XXX XXX
Net Debt n/a $5.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Imricor Medical Systems Stock Performance

As of April 15, 2025, Imricor Medical Systems's stock price is AUD 1 (or $1).

Imricor Medical Systems has current market cap of AUD 452M (or $284M), and EV of AUD 460M (or $289M).

See Imricor Medical Systems trading valuation data

Imricor Medical Systems Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$289M $284M XXX XXX XXX XXX $-0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Imricor Medical Systems Valuation Multiples

As of April 15, 2025, Imricor Medical Systems has market cap of $284M and EV of $289M.

Imricor Medical Systems's trades at 155.8x LTM EV/Revenue multiple, and -19.0x LTM EBITDA.

Analysts estimate Imricor Medical Systems's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Imricor Medical Systems and 10K+ public comps

Imricor Medical Systems Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $289M XXX XXX XXX
EV/Revenue 479.9x XXX XXX XXX
EV/EBITDA -15.9x XXX XXX XXX
P/E -15.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -29.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Imricor Medical Systems Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Imricor Medical Systems Valuation Multiples

Imricor Medical Systems's NTM/LTM revenue growth is 331%

Imricor Medical Systems's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Imricor Medical Systems's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Imricor Medical Systems's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Imricor Medical Systems and other 10K+ public comps

Imricor Medical Systems Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 56% XXX XXX XXX XXX
EBITDA Margin -3015% XXX XXX XXX XXX
EBITDA Growth 32% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -2683% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 237% XXX XXX XXX XXX
G&A Expenses to Revenue 513% XXX XXX XXX XXX
R&D Expenses to Revenue 853% XXX XXX XXX XXX
Opex to Revenue 1682% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Imricor Medical Systems Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Imricor Medical Systems M&A and Investment Activity

Imricor Medical Systems acquired  XXX companies to date.

Last acquisition by Imricor Medical Systems was  XXXXXXXX, XXXXX XXXXX XXXXXX . Imricor Medical Systems acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Imricor Medical Systems

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Imricor Medical Systems

When was Imricor Medical Systems founded? Imricor Medical Systems was founded in 2006.
Where is Imricor Medical Systems headquartered? Imricor Medical Systems is headquartered in Australia.
Is Imricor Medical Systems publicy listed? Yes, Imricor Medical Systems is a public company listed on ASX.
What is the stock symbol of Imricor Medical Systems? Imricor Medical Systems trades under IMR ticker.
When did Imricor Medical Systems go public? Imricor Medical Systems went public in 2019.
Who are competitors of Imricor Medical Systems? Similar companies to Imricor Medical Systems include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Imricor Medical Systems? Imricor Medical Systems's current market cap is $284M
What is the current revenue of Imricor Medical Systems? Imricor Medical Systems's last 12-month revenue is $3.0M.
What is the current EBITDA of Imricor Medical Systems? Imricor Medical Systems's last 12-month EBITDA is -$24.2M.
What is the current EV/Revenue multiple of Imricor Medical Systems? Current revenue multiple of Imricor Medical Systems is 155.8x.
What is the current EV/EBITDA multiple of Imricor Medical Systems? Current EBITDA multiple of Imricor Medical Systems is -19.0x.
What is the current revenue growth of Imricor Medical Systems? Imricor Medical Systems revenue growth between 2023 and 2024 was 56%.
Is Imricor Medical Systems profitable? Yes, Imricor Medical Systems is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.